Search Results - "Kessler, PD"

Refine Results
  1. 1

    Myoblast cell grafting into heart muscle: cellular biology and potential applications by Kessler, P D, Byrne, B J

    Published in Annual review of physiology (01-01-1999)
    “…This review surveys a wide range of cellular and molecular approaches to strengthening the injured or weakened heart, focusing on strategies to replace…”
    Get full text
    Journal Article
  2. 2

    Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart by TOMA, Catalin, PITTENGER, Mark F, CAHILL, Kevin S, BYRNE, Barry J, KESSLER, Paul D

    Published in Circulation (New York, N.Y.) (2002)
    “…Cellular cardiomyoplasty has been proposed as an alternative strategy for augmenting the function of diseased myocardium. We investigated the potential of…”
    Get full text
    Journal Article
  3. 3

    Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic by Hatsukami, DK, Jorenby, DE, Gonzales, D, Rigotti, NA, Glover, ED, Oncken, CA, Tashkin, DP, Reus, VI, Akhavain, RC, Fahim, REF, Kessler, PD, Niknian, M, Kalnik, MW, Rennard, SI

    Published in Clinical pharmacology and therapeutics (01-03-2011)
    “…NicVAX, a nicotine vaccine (3′AmNic‐rEPA), has been clinically evaluated to determine whether higher antibody (Ab) concentrations are associated with higher…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Gene Delivery to Skeletal Muscle Results in Sustained Expression and Systemic Delivery of a Therapeutic Protein by Kessler, Paul D., Podsakoff, Gregory M., Chen, Xiaojuan, McQuiston, Susan A., Colosi, Peter C., Matelis, Laura A., Kurtzman, Gary J., Byrne, Barry J.

    “…Somatic gene therapy has been proposed as a means to achieve systemic delivery of therapeutic proteins. However, there is limited evidence that current methods…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Correction of the Enzymatic and Functional Deficits in a Model of Pompe Disease Using Adeno-associated Virus Vectors by Fraites, Thomas J., Schleissing, Mary R., Shanely, R.Andrew, Walter, Glenn A., Cloutier, Denise A., Zolotukhin, Irene, Pauly, Daniel F., Raben, Nina, Plotz, Paul H., Powers, Scott K., Kessler, Paul D., Byrne, Barry J.

    Published in Molecular therapy (01-05-2002)
    “…Pompe disease is a lysosomal storage disease caused by the absence of acid α-1,4 glucosidase (GAA). The pathophysiology of Pompe disease includes generalized…”
    Get full text
    Journal Article
  10. 10

    Sudden cardiac death in heart failure : the role of abnormal repolarization by TOMASELLI, G. F, BEUCKELMAN, D. J, CALKINS, H. G, BERGER, R. D, KESSLER, P. D, LAWRENCE, J. H, KASS, D, FELDMAN, A. M, MARBAN, E

    Published in Circulation (New York, N.Y.) (01-11-1994)
    “…Congestive heart failure is a common, highly lethal cardiovascular disorder claiming over 200,000 lives a year in the United States alone. Some 50% of the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model by Wang, Kai, Kessler, Paul D, Zhou, Zhongmin, Penn, Marc S, Forudi, Farhad, Zhou, Xiaorong, Tarakji, Khaldoun, Kibbe, Melina, Kovesdi, Imre, Brough, Douglas E, Topol, Eric J, Lincoff, A.Michael

    Published in Molecular therapy (01-05-2003)
    “…In this study the effect of local adenoviral-mediated delivery of inducible nitric oxide synthase on restenosis was evaluated in a porcine coronary stented…”
    Get full text
    Journal Article
  13. 13

    Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease by Pauly, D F, Fraites, T J, Toma, C, Bayes, H S, Huie, M L, Hirschhorn, R, Plotz, P H, Raben, N, Kessler, P D, Byrne, B J

    Published in Human gene therapy (20-03-2001)
    “…Pompe disease is a lethal cardioskeletal myopathy in infants and results from genetic deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). Genetic…”
    Get more information
    Journal Article
  14. 14

    Increased revascularization efficacy after administration of an adenovirus encoding VEGF by Perrin, L A, June, J E, Rosebury, W, Robertson, A, Kovesdi, I, Bruder, J T, Kessler, P D, Keiser, J A, Gordon, D

    Published in Gene therapy (01-03-2004)
    “…Adenovirus-mediated VEGF gene delivery is being evaluated in clinical trials as a treatment for patients with vascular diseases that stem from ischemia, such…”
    Get full text
    Journal Article
  15. 15

    Prevention and reversal of nitrate tolerance in patients with congestive heart failure by Packer, M, Lee, W H, Kessler, P D, Gottlieb, S S, Medina, N, Yushak, M

    Published in The New England journal of medicine (24-09-1987)
    “…To evaluate possible mechanisms underlying the development of nitrate tolerance, we treated 35 patients who had severe chronic heart failure with a prolonged…”
    Get more information
    Journal Article
  16. 16

    Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts by Robinson, S W, Cho, P W, Levitsky, H I, Olson, J L, Hruban, R H, Acker, M A, Kessler, P D

    Published in Cell transplantation (01-01-1996)
    “…The ability to replace damaged myocardial tissue with new striated muscle would constitute a major advance in the treatment of diseases that irreversibly…”
    Get more information
    Journal Article
  17. 17

    Complete correction of acid α-glucosidase deficiency in pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle by PAULY, D. F, JOHNS, D. C, MATELIS, L. A, LAWRENCE, J. H, BYRNE, B. J, KESSLER, P. D

    Published in Gene therapy (01-04-1998)
    “…The enzyme acid alpha-glucosidase catalyzes the breakdown of lysosomal glycogen. Absence of this enzyme results in infantile Pompe disease, characterized by…”
    Get full text
    Journal Article
  18. 18

    Nucleotide sequences of avian cardiac and brain SR/ER Ca2+-ATPases and functional comparisons with fast twitch Ca2+-ATPase: calcium affinities and inhibitor effects by CAMPBELL, A. M, KESSLER, P. D, SAGARA, Y, INESI, G, FAMBROUGH, D. M

    Published in The Journal of biological chemistry (25-08-1991)
    “…Two similar forms of the cardiac/slow Ca2+-ATPase (SERCA2a and SERCA2b), differing in sodium dodecyl sulfate-polyacrylamide gel electrophoresis mobility, are…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes by Inesi, G, Lewis, D, Sumbilla, C, Nandi, A, Strock, C, Huff, K W, Rogers, T B, Johns, D C, Kessler, P D, Ordahl, C P

    Published in The American journal of physiology (01-03-1998)
    “…Adenovirus-mediated transfer of cDNA encoding the chicken skeletal muscle sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA1) yielded selective expression in…”
    Get full text
    Journal Article